-+ 0.00%
-+ 0.00%
-+ 0.00%

HALOZYME THERAPEUTICS, INC. : LEERINK PARTNERS CUTS TO MARKET PERFORM FROM OUTPERFORM; RAISES TARGET PRICE TO $117.00 FROM $110.00

Reuters·11/06/2026 15:17:53

Please log in to view news